The ICH Drug Interaction Studies M12 Draft Guideline Now Available Online

15 July 2022 — ICH announced the availability of the M12 draft guideline presentation.

This Guideline provides general recommendations on how to evaluate the DDI (drug-drug interaction) potential of an investigational drug. It is recognized that the DDI evaluation is generally tailored based on the specific drug, intended patient population, and therapeutic context.

Read the pdf 
Copyright Widler & Schiemann AG 2020. All Rights Reserved. /